Computed Tomography Laser Mammography Breast Imaging Device
- Conditions
- Breast Cancer
- Registration Number
- NCT00589043
- Lead Sponsor
- Imaging Diagnostic Systems
- Brief Summary
The purpose of this study is to evaluate the sensitivity and specificity of the CTLM system when used adjunctively with mammography compared to mammography alone in the heterogeneously and extremely dense breast population.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- Female
- Target Recruitment
- 600
Inclusion Criteria
- Female
- 21 and over
- Heterogeneously or extremely dense breast
- Schedule for biopsy
- Gave informed consent
Exclusion Criteria
- Mammogram not performed within the last 60 days
- Open lesions on the breast
- Previous breast biopsy within 60 days of the CTLM scan
- Surgical deformity of breasts
- Commercial Tattoos
- Protoporphyria
- Lactating
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie CTLM's improved sensitivity in dense breast tissue compared to traditional mammography?
How does the CTLM system compare to MRI and ultrasound in detecting breast cancer in dense breast populations?
Which biomarkers are associated with enhanced detection rates using CTLM in heterogeneously dense breasts?
What are the potential adverse events linked to laser-based breast imaging in clinical practice?
Are there combination imaging strategies that integrate CTLM with other modalities for better breast cancer screening?